What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Groups Pneumology Groups Research on Aging, Frailty and Transitions in Barcelona Groups Molecular Imaging and Therapy Groups Ophtalmology Groups Kidney Physiopathology Groups Neurovascular Diseases Groups Nephrology and kidney transplantation Groups Diabetes and Metabolism Groups Cardiovascular Diseases Groups Protein kinases in cancer research Groups Biomedical Research in Melanoma Groups Childhood Cancer and Blood Disorders Groups Head and Neck Cancer: Biomedical Research Cancer Stem cells Groups Translational Molecular Pathology Groups Biomedical Research in Urology Groups Biomedical Research in Gynaecology Activities Activitats solidàries jornades científiques-tecnològiques La Comissió JCT de l’Institut Agustí Serra i Fontanet organitza les I Jornades Científiques-Tecnològiques. Apropant l’alumnat a la ciència, la tecnologia i la salut. Visibilitzant la importància de la recerca en la prevenció i tractament de malalties.Les jornades neixen amb l’objectiu de m A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping with an Initial Multiple Ascending Dose Part A to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ENTR-601-45, Followed by Part B to Evaluate the Safety and Efficacy of ENTR-601-45 (ELEVATE-45) Contact Protocol code: ENTR-601-45-201 EudraCT code: 2024-517499-39-00 Pathology: Duchenne muscular dystrophy Pharmac: ENTR-601-45 Promoter: Entrada Therapeutics, Inc. Principal investigator: Gómez Andrés, David Research group: Teràpies i Innovació en Neuropediatria i altres malalties rares pediàtriques. Service: Neurologia pediàtrica Phase: Fase I Recruiting: Open Status: Activo Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. An Open-Label Extension Study of EryDex in Patients with Ataxia Telangiectasia Following Participation in Study IEDAT-04-2022 (NEAT) Contact Protocol code: IEDAT-05-2024 EudraCT code: 2024-513618-37-00 Pathology: Ataxia Telangiectasia (A-T) Pharmac: EryDex Promoter: Quince Therapeutics S.p.A. Principal investigator: Gómez Andrés, David Research group: Teràpies i Innovació en Neuropediatria i altres malalties rares pediàtriques. Service: Neurologia pediàtrica Phase: Fase III Recruiting: Open Status: Activo Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44 (ELEVATE-44) Contact Protocol code: ENTR-601-44-201 EudraCT code: 2024-517584-23-00 Pathology: Duchenne muscular dystrophy Pharmac: Hydrocortisone Promoter: Entrada Theraputics, Inc. Principal investigator: Gómez Andrés, David Research group: Teràpies i Innovació en Neuropediatria i altres malalties rares pediàtriques. Service: Neurologia pediàtrica Phase: Phase I Recruiting: Open Status: Activo Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Pagination First page « Previous page ‹ … Page 270 Page 271 Current page 272 Page 273 Page 274 … Next page › Last page »
